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1. Introduction 
 
This article examines the application of liquid chromatography 
high resolution mass spectrometry (LCHRMS) in metabolomic 
profiling in relation to metabolite identification. The review focuses 
on metabolomics in metazoans since the issues with regard to 
identification are different to the issues with regard metabolite 
identification in plants and microbes, but not necessarily simpler. On 
the one hand the diversity of chemical structures in plants and 
microbes is huge in comparison with metazoans but on the other 
these metabolites can often be obtained in large quantities and are 
amenable to isolation and characterisation by nuclear magnetic 
resonance spectroscopy (NMR). Identification of metabolites can be 
a problem in mass spectrometry based metabolomics [1-7] but 
sometimes the issue is made to seem more difficult than it actually is. 
If the goal of a metabolomics study is to monitor well characterised 
metabolites for instance in disease monitoring, then low resolution 
mass spectrometry might be more appropriate since the target 
compounds are known and tandem mass spectrometry is a method 
which is highly standardised with regard to being able to obtain 
quantitative accuracy. Some research groups have set up more specific 
biomarker screens based on low resolution tandem mass spectrometry 
where a large number of standard compounds have been used to 
standardise the methods [8-13]. However, for many research groups 
biomarker discovery remains a more general screening operation. Gas 
chromatography mass spectrometry (GC-MS)  remains a widely used 
general screening process and is very effective for the wide range of 
compounds which are either volatile or can be rendered volatile 
through derivatisation [14-16] . It has the advantage that capillary gas 
chromatography is inherently a much higher resolution separation 
technique than liquid chromatography and thus there are fewer issues 
with the separation of  isobaric  or  isomeric  compounds. In addition  
  
 
 
 
 
 
 
the electron impact ionisation spectra produced by GC-MS provide a 
complex fingerprint which, when matched against library spectra, can 
differentiate between closely similar compounds such as isomers [1]. 
The limitation of GC-MS is that there are a large number of 
compounds within metabolomes which are not volatile or are unstable 
at the high temperatures required for GCMS. Thus this article focuses 
on how metabolites can be identified by using LCHRMS.  
 
2. Identification in Mass Spectrometry 
 
Although there are thousands of metabolites in biological systems 
the level of the challenge of identifying them can immediately be 
reduced if the interest is purely in identifying those that change in the 
system under investigation. The numbers of metabolites changing in 
response to for instance diseased vs healthy controls may be only tens 
of metabolites rather than thousands [16-30]. These are the 
compounds which hold the most interest with regard to identification 
since they might be used to support a particular hypothesis or 
diagnose a particular disease. The metabolomics standards initiative 
indicated different levels of identification of compounds in mass 
spectrometry [31, 32].   
 
3. Elemental Composition 
 
The most basic level of identification obtained using mass 
spectrometry is the molecular weight of a metabolite. When high 
resolution mass spectrometry is used the accurate molecular mass 
obtained can be assigned to a particular molecular formula. 
Experimentally measured masses are rarely exactly the same as a 
proposed molecular formula, so a formula will be assigned by 
software which has a mass deviation from the exact mass measured in 
ppm (ppm = (deviation  of measured mass in atomic mass 
units/exact molecular weight)x106). The size of the deviation impacts 
on the confidence with which an elemental formula can be assigned to 
a mass. The degree of mass deviation depends on the type of ion 
separation method used to generate the mass spectrum. There are 
three major types of mass spectrometer used in high resolution 
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measurements in metabolomics: Time of flight mass spectrometers 
(TOFs), ion cyclotron resonance mass spectrometers and Orbitraps. 
Mass accuracy performance is approximately as follows: TOF 
instruments ca 1-2 ppm, Orbitraps ca 1  ppm, ion cyclotron 
resonance ca 0.1 ppm [1, 34-40]. A more detailed discussion of these 
instruments can be found elsewhere [34, 39, 40]. In addition, optimal 
performance of an instrument depends on the instrument having been 
recently calibrated against compounds of known molecular weight 
and on the choice of suitable lock masses. A lock mass is an exact 
mass which is used to correct for any instrument drift during an 
analysis. Often in TOF instruments a compound which is to be used 
as a lock mass is continuously infused into the mass spectrometer ion 
source during a run. Alternatively the lock mass may be one or several 
background ions which are present throughout the analytical run such 
as ions generated from the solvents used in the chromatographic 
separation which are continuously being introduced into mass 
spectrometer source along with the ions of interest. When working 
with mass accuracy at < 3 ppm there is generally no difficulty in 
separating compounds with the same nominal mass. To get an idea of 
what ppm separation means in practical terms table 1 lists compounds 
with masses between 132.05-132.12 with their ppm deviations from 
the preceding masses in the table. As can be seen in table 1, a high 
resolution mass spectrometer would have little trouble in 
distinguishing these isobaric compounds and the main problem, if for 
instance hydroxyproline was an important marker, would be in 
distinguishing it from its isomers. 
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As the mass of a compound increases the number of possible 
combinations of elements which can add up to make its exact mass 
increases. The simplest way to evaluate the impact of the ppm 
deviation of the measured mass on correct assignment of elemental 
composition is to look at some examples. However, firstly we must 
consider which elements we should include in the search. Table 2 lists 
the exact masses of biologically relevant elements, which are covalently 
bound in naturally occurring organic compounds, along with their 
isotopes. The list could be slightly wider but selenium is so rare that 
is not worth considering as a standard element to search for unless it 
is particularly abundant and the same is true of boron and silicon 
which may occur in specific biological systems. Halogens occur only 
rarely in biomolecules such as iodine in thyroxine, in specific 
biological systems or as xenobiotics in a particular biological system. 
Chlorine and bromine are instantly recognisable because of their 
characteristic isotope patterns. Metal ions are generally not covalently 
bound to organic molecules, there are obviously some exceptions, 
although they can contribute adducts to mass spectrometric data. 
Thus to keep it simple, for the purposes of this short review, it is a 
safe bet that  the vast majority of compounds occurring in a biological 
system contain H,C,O,N,P,S, in that order of frequency of 
occurrence. Xenobiotics can confound this view but their occurrence 
is often idiosyncratic and thus they would not be picked up as a 
significant difference between a treated and control group unless of 
course, for instance, a drug treatment regimen was being studied. 
 
 
 
4. The Assignment of Elemental Composition 
 
Kind et al defined a formal set of rules for confirmation of the 
correct elemental composition for compounds according to their mass 
spectra [41]. Below these rules are restated simply for use with high 
resolution masses. These rules are not definitive but they present a 
simple first pass method for evaluating unknown metabolites. 
 
1. Formula containing any combination of carbon, hydrogen, 
sulphur and oxygen, not necessarily all of these elements, cannot 
have an even MW in their protonated or deprotonated form 
(some compounds are fractionally (< 0.1 amu) below their 
nominal mass e.g. the negative ion of fructose bisphosphate 
(C6H13O12P2) has a mass of 338.9888 which for the purposes 
of this rule is regarded as 339). 
2. Formulae containing odd numbers of nitrogen atoms have even 
MWs in their protonated or deprotonated forms. 
3. Formulae containing even numbers of nitrogen atoms have odd 
MWs in the protonated or deprotonated form. 
4. Apart from for peptides it would be unusual to find more than 
7 nitrogens in a structure. 
5. It would be unusual for the number of oxygens to be more than 
one greater than the number of carbons. The number of 
nitrogens in a structure would be unlikely to exceed the number 
of carbons. The sum of nitrogens and oxygens would be 
unlikely to exceed the number of carbons. This rule does not 
always apply if there is one or more phosphorus atoms in the 
composition. 
6. It would be unusual to find more than two sulphur or more 
than three phosphorus atoms in a structure. 
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7. One phosphorus requires at least four oxygens (usually found 
with 6 or more) in a formulae, two phosphorus atoms at least 
seven oxygens, three phosphorus atoms at least nine oxygen 
atoms. 
8. Molecules containing both phosphorus and sulphur are 
relatively rare. 
9. A degree of unsaturation (RDB equiv.) > 20 would be unusual 
for a low MW metabolite. 
10. Assuming the instrument is tuned sufficiently well to give 
known marker metabolites accurate masses with < 1.5 ppm 
deviation, elemental compositions > three times the deviation 
for the first acceptable composition should be rejected. This 
rule should be applied in an iterative fashion if the first 
acceptable composition is rejected since it is absent from the 
databases. 
 
Thus these rules can provide a framework for simply evaluating an 
elemental composition. It is not likely in practice that the sort of 
exercise described below would be carried out ahead of a database 
match. However, if the exact mass was not in the database then they 
could be useful. They are not perfect but neither are they complex.  
With these rules in mind it is possible to look at some examples. The 
restrictions applied to the formulae shown in table 3 in terms of 
number of elements allowed were C60 H100 N7 O20 P4 S2 with a 
RDB ≤ 20. The first example is for a compound with a measured at 
744.08258 amu in positive ion mode on an Orbitrap Exactive. The 
high MW means that the possible variations in elemental composition 
are large. 
 
 
 
Thus there are two possible hits for this compound according to 
the rules. In practise automatic comparison against a database of 
accurate masses would be used to assign an identity to a metabolite. 
There are a number of databases which contain high resolution mass 
values of metabolites including the human metabolome database [42], 
KEGG [43], LipidMaps [44], ChemSpider 
(http://www.chemspider.com/) Metlin [45] and PubChem 
(http://pubchem.ncbi.nlm.nih.gov/). PubChem is the largest 
database of chemical compounds available but it contains many 
synthetic as well as naturally occurring compounds. Manually 
searching against PubChem returns no matches for hit 3. Searching 
the composition of hit 4 against PubChem returns 14 hits and only 
one of these corresponds to a naturally occurring metabolite, 
NADP+. Another example is a compound with a measured mass in 
positive ion mode of m/z 613.1598. This example is more 
challenging since the mass deviation for the metabolite is greater than 
the example above. The first match in PubChem is for hit 17 which 
matches oxidised glutathione (GSSG). Below this in the table there 
are no matches until formula 31 which matches a series of synthetic 
anti-tumour agents with complex non-biological structures. Hit 33 
gives a match to a single compound in PubChem which is a 
polyphosphate sugar. In theory such structures could occur in nature 
but this is a synthetic compound. It is unlikely that one would often 
go through this laborious way of assigning a structure since database 
matching eliminates any compounds which are not known 
biomolecules. However, in the case of a complete unknown 
compound manual checking would be a component in deciding 
whether or not a hit seemed genuine. It is notable for the two 
examples given that the most frequently applied rules are the nitrogen 
rules 2 and 3. 
 
5. Isotope Patterns 
 
A high resolution spectrum contains additional information 
relating to the molecular ion in the form of an isotope pattern (see 
isotopes listed in table 2). The exactness of the correspondence of the 
isotope pattern to the theoretical pattern depends on the type of ion 
separation device used. TOF instruments give isotope ratios closer to 
the predicted level since there is no requirement to have a cut off level 
for low abundance ions. Ion trap instruments such as the Orbitrap 
have to limit trap fill due to space charge effects which produce 
interference between ions in the trap if it becomes too full. Thus traps 
have a cut off for low abundance ions to prevent overfilling of the 
trap with ions which are essentially due to background noise. Software 
is available for correlating observed against theoretical isotope 
patterns and is either provided by vendors is available for free 
download [46]. The example of GSSG discussed above was obtained 
at high resolution on an Orbitrap but even at 50000 resolution for a 
large molecule like GSSG resolution between 15N, 17O and 13C peaks 
is not achieved and the ions sum into a single ion for the M+1 peak. 
 
In theory GSSG (C20H33O12 N6S2) contains the following 
isotope patterns calculated from the abundances in table 1.  
1. M+1 peak 20 x 1.08 (13C) + 0.37 x 6 (15N) + 0.21 x 12 (17O) 
= 26.34%. In fact it is present at 19.9 % abundance due to the 
cut off level in the ion trap is thus not an exact match to theory.  
2. More specific with regard to confirming identity is the presence 
of a peak at 615.1572 which is due to the 34S isotope (2x 
4.52%) which is very characteristic of sulphur containing 
compounds. The other elements contribute very little at 2 amu 
higher than the molecular ion and thus the abundance of the 
[MH]+ +2 peak is in theory 9.04% but in the spectrum 
obtained from the sample it is 5.5%, the effect of the trap cut 
off becomes more marked for low intensity ions. However, the 
presence of this ion, despite the deviation from expected 
intensity, is very characteristic of a sulphur containing 
compound.  
 
Isotope ratios can provide a quick check of whether or not a 
proposed formula makes sense. Figure 2 shows a comparison of the 
spectra of hippuric acid and glucosamine. These compounds are close 
in mass but have different numbers of carbon atoms and this can be 
immediately seen from the height of the 13C-isotope peak. 
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6. Misidentification of Isotope Peaks 
 
It is worth noting that isotope peaks can cause some false hits in 
terms of identification. Data extraction software can be used to filter 
out isotope peaks but this is a double edged sword since if the isotope 
peak matches a genuine compound then the genuine hit would be lost 
unless there was clear chromatographic separation. Returning to the 
GSSG 34S isotope peak which has a mass 615.1536, searched against a 
database this give a match to within -1.6 ppm for cytidine 
monophosphate N-acetylneuraminic acid (KEGG entry 
C00128).There are probably numerous examples of this type of 
confusion. Two other examples are: Methyl dihydropterin (m/z 
178.0723) due to the acetonitrile adduct of hypoxanthine and 
deoxyribose phosphate (m/z 215.0331) due to a 35Cl- adduct of a 
hexose.  
 
 
 
 
 
 
 
 
7. Identification of isomers 
 
The most common problem of identification in high resolution 
mass spectrometry is in the identification of isomers. There are two 
strategies available for isomer identification they can either be 
separated chromatographically and matched against standards or they 
can be differentiated by fragmenting their molecular ions to produce a 
mass spectrum where the fragments can be used to characterise the 
Figure 1. Molecular ion of GSSG extracted from mammalian cells with 
associated isotope peaks.  
 
Figure 2. Comparison of the 13C-isotope peaks for glucosamine and 
hippuric acid. The observed intensity values were glucosamine 5.5 % 
(theoretical 6.8%, the 17O peak is resolved) and hippuric acid 9.5% 
(theoretical 9.9%, the 17O peak is resolved). 
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molecule of interest. The most reliable method for characterising 
isomers is to achieve chromatographic separation since the fragments 
derive from MS/MS or MS2 are often not definitive and if the two 
isomers overlap chromatographically this will confuse the issue still 
further. However, setting up a chromatographic method to separate 
isomers relies on having authentic standards of the molecules of 
interest, although retention time prediction on the basis of proposed 
structure can also be helpful [47]. Figure 3 shows an extracted ion 
trace for dihydroxyacetone phosphate (DHP) and glyceraldehyde 
phosphate (GP) extracted from a mammalian cell culture on a 
ZICpHILIC column which produces separation of these two isomers. 
The additional peak in the trace with the same elemental composition 
is formed by low level fragmentation of fructose 1,6-diphosphate 
(F1,6P)in the mass spectrometer. F1,6P is the biosynthetic precursor 
of DHP and FP. 
 
 
 
 
 
 
 
In fact DHP and GP can be distinguished by MS2 since GP is 
able to readily eliminate water as DHP cannot (Figure 4). 
 
 
 
 
In contrast figure 5 shows a mixture of sugar phosphates partially 
separated on a Cogent Silica C column. In the absence of 
chomatographic separation between isomers then it is necessary to 
determine whether or not fragmentation can distinguish between 
isomeric compounds. In case of sugar phosphates there are some 
differences between tandem MS or MS2 spectra [48] of the 
compounds but the most reliable method for distinguishing between 
these isomers would be chromatographic resolution. There is only one 
commonly available method which can chromatographically separate 
common sugar phosphates such as glucose and fructose 1 and 6 
phosphates and that is ion chromatography carried out at high pH. 
This method exploits the differences in the pKa values of the different 
hydroxyl groups in the sugars; the hydroxyl groups are appreciably 
ionised at pH 14 [49].  
 
 
 
 
 
 
 
 
8. Tandem MS and MS2 Spectra 
 
Distinguishing between isobaric compounds is much easier than 
distinguishing between isomers.  
Figure 6 shows an extracted ion trace for metabolites in human 
urine in the range 245.0-245.2 amu. There are four major metabolites 
evident in this range. The molecular ion composition and MS2 data 
for these compounds is shown in table 5. Two of the exact masses 
match compounds in Pubchem and other databases and as can be seen 
in table 5 they give completely different spectra. Many of the rules for 
fragmentation in mass spectrometry derive electron impact spectra. 
There have been no definitive rules determined for likely 
fragmentation pathways by tandem MS or MS2  and it is only 
presumed that similar fragmentation rules apply as were determined 
for EI conditions. As can be seen in figure 7, where the 
fragmentations of biotin and uridine are rationalised, fragmentation is 
not necessarily straightforward. In the present case it is possible to 
explain the fragmentation but that is with knowing what the 
compounds are derived from a database match to the elemental 
composition. This would be less straightforward for a completely 
unknown structure. Thus mass spectra are often used as a fingerprint 
without any attempt at interpretation. However, with no database 
match and no authentic standard to match against a fingerprint is no 
use.  Another problem is indicated in figure 8 where the mass spectra 
of uridine and pseudouridine in urine are compared. Both compounds 
are RNA metabolites but pseudouridine is much less abundant in 
RNA and thus at lower levels in urine. The exact mass of 
pseudouridine is very close to that of biotin which more or less 
overlaps with it chromatographically and the more abundant ions in 
Figure 3. Extracted ion trace for dihydroxyacetone phosphate and 
glyceraldyde phosphate extracted from mammalian cells separated on a 
ZICpHILIC column. 
 
Figure 4. MS2 spectra of DHP and GP in negative ion mode (CID 35 V). 
 
Figure 5. Extracted ion chromatogram for standard sugar phosphates on a 
250 mm 4.6 mm Cogent silica C column showing incomplete resolution 
sugar phosphates. 
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the spectrum are due to biotin. However, it is possible to see fragment 
ions at 227.0662 due to loss of water from pseudouridine and there is 
also a peak 113.03 due to loss of the ribose moiety. If pseudouridine 
was unknown if might be easy in the current example to confuse its 
MS2 spectrum with that of biotin. The metabolite at 5.8 min did not 
give a match to the database and its fragment ion was not helpful with 
regard to understanding the structure, it might be that MS3 would 
help to elucidate the structure of the fragment ion but the structure is 
quite unusual in being highly unsaturated. The metabolite at 11.2 min 
did not return a sensible elemental composition within a ± 3 ppm 
window; however, on closer inspection it is the 13C-isotope peak of a 
metabolite at m/z 244.1542 which is probably pentenoylcarnitine 
since its shows loss of 59 amu in its MS2 spectrum which is typical of 
carnitines. 
 
 
 
 
 
 
 
 
 
9. Tandem MS and MSn in Metabolomics Studies 
 
Many mass spectrometry based metabolomics studies have based 
their identification of metabolites on the combination of assignment 
of elemental composition to a metabolite peak and the matching of 
retention times to the retention times of standards. This is quite 
reasonable since this is a very specific method already. However, 
sometimes standards are not available and if a marker compound is 
significant it is important to characterise it by using tandem MS or 
MS2. Many papers used fragmentation as additional confirmation of 
compound  identity [16-30] but in these papers there is often no 
discussion the MS/MS spectra since standards are available. The 
Metlin data base has recorded MS/MS spectra for many naturally 
occurring metabolites and xenobiotics (http://metlin.scripps.edu) 
obtained on an Agilent QTOF instrument. MS/MS spectra vary a 
great deal according to the instrument used, the collision energy used, 
the collision gas used and the collision gas pressure. More extensive 
interpretation of mass spectra is required where there is no standard 
available. There are surprisingly few papers metabolomics papers, 
studying higher organisms, where the details of structure elucidation 
of marker compounds have been reported and even many of these do 
not give full details such collision energy and the gas used for CID. 
Table 6 summarises some recent studies where fragmentation was 
used to elucidate the structure and details of the fragmentation 
patterns observed were given. 
 
 
 
 
 
 
Figure 6. Extracted ion trace over the range m/z 245.0-245.2 of 
metabolites in human urine. 
Figure 7. Major MS2 fragmentation pathways for biotin and uridine. 
Figure 8. MS2 spectra of A Uridine B Pseudouridine + biotin. 
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If MS/MS or MS2 spectra do not provide complete structure 
elucidation it is possible to use MSn on ion trap instruments to 
fragment the fragment ions produced in MS2 experiments further. Of 
course this may not always work since the fragment ions produced at 
the first iteration tend to be stable ions. There is a current trend to 
move towards MSn identification using spectral trees [62-64] but this 
is perhaps overkill for the identification of routine metabolites where 
standards are available, however, it is useful where a complete 
unknown metabolite is being elucidated. 
 
10. Other Factors Supporting Compound Identification 
 
Studies where metabolite hits fall into a single or into closely 
related metabolic pathways generate greater confidence in the 
identification of the metabolites within those pathways. Random hits 
standing in isolation from a defined metabolic pathway are less 
satisfactory. There are examples of metabolomics studies where the 
metabolites identified as being changed are metabolically related to 
each other [16, 64-67] but there are many more where the metabolite 
changes are seemingly random. Another strategy for identifying 
metabolites is to predict metabolites in a series. For example 
phenylacetyl glutamine is an abundant urinary metabolite but no other 
fatty acid conjugates of this type had been described. It was possible 
explain a number of metabolites in urine through predicting that 
other conjugates in this series would be present by simply making a 
synthetic list of metabolites with the appropriate exact mass by 
combining fatty acid acyl moieties and glutamine [68]. 
 
11. Conclusion 
 
In this short review I have tried to simplify the process of 
metabolite ID by breaking it down into discrete steps. When using 
high resolution mass spectrometry to identify metabolites in 
conjunction with a database search, most often the major challenges 
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are chromatographic rather than mass spectrometric since it important 
to ensure that isomeric compounds are separated. It is important to 
distinguish challenge of working with metabolites in metazoan 
systems from the more complex challenges of identifying metabolites 
in plants. The range of metabolites in metazoan systems is much more 
restricted than that in plants. However, low levels of unknown 
metabolites are likely to remain difficult to identify since the only 
definitive technique for full structure elucidation is NMR which 
requires mg amounts of material, although the use of capillary NMR 
tubes can reduce this. Surveying the literature there are not that many 
examples where an unknown metabolite highlighted in a 
metabolomics screen has been identified by mass spectrometry. This is 
likely to change as applications of metabolomics increase. However, 
the lack of clear examples MS/MS or MSn structural ID experiments 
in metabolomics in metazoans makes it difficult to assess the 
effectiveness of these methods. It can be particularly difficult to get 
useful information when dealing with compounds with low intensity 
signals where clear fragmentation patterns may not be obtained.  
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